Skip to Main Navigation Skip to Main Content Skip to Footer
search play2 play3 facebook twitter linkedin2 cross instagram
ASCP
  • DASHBOARD
  • STORE
  • LOGOUT
  • STORE
  • LOGIN
Menu
  • Jobs
  • ASCP
  • User Auth Test Page
  • US Surgeon General Releases “Step-By-Step” Toolkit To Help Combat COVID-19 Vaccine Misinformation

    ABC News (11/9, Haslett) reports US Surgeon General Dr. Vivek Murthy “released a step-by-step toolkit Tuesday morning to help people combat misinformation about the COVID-19 vaccines in their own close circles.” The new guide “includes discussion question...
    Full Article
  • Nearly 80% Of Americans Have Heard Some Misinformation About COVID-19, Data Suggest

    CNN (11/9, Stelter, Langmaid, Business) reports “most American adults have heard at least” some misinformation about COVID-19, “according to new data from the Kaiser Family Foundation.” KFF surveyed Americans by testing eight false statements about COVID-...
    Full Article
  • People Who Are Fully Vaccinated Against COVID-19 Appear 16 Times Less Likely To Present In ICU, Die Than Those Not Immunized, Australian Study Suggests

    Bloomberg (11/9) reports, “People who are fully vaccinated are 16 times less likely to end up in intensive care or to die from Covid-19 than those who aren’t immunized, an Australian government study [PDF] found.” According to the data, “nearly 16 out of...
    Full Article
  • Positive Pneumococcal Urinary Antigen Test Tied To Earlier De-Escalation Of Antimicrobials Among Patients With Community-Acquired Pneumonia Versus Negative Test, Study Indicates

    Healio (11/9, Stulpin) reports, “Among patients with community-acquired pneumonia, receipt of a positive pneumococcal urinary antigen test was associated with earlier de-escalation of antimicrobials compared with patients who received a negative test, acc...
    Full Article
  • All Frontline Health Workers In England To Be Required To Receive COVID-19 Vaccine By April 1

    The New York Times (11/9, Castle) reports that “all frontline health workers in England will have to be vaccinated against Covid-19 by next spring to keep their jobs,” Secretary of State for Health and Social Care Sajid Javid announced Tuesday, “a move th...
    Full Article
  • US Purchases 1.4M More Courses Of Merck’s Molnupiravir For $1B

    Reuters (11/9, Mishra) reports, “Merck & Co Inc and partner Ridgeback Biotherapeutics said on Tuesday the U.S. government would pay about $1 billion to buy an additional 1.4 million courses of their COVID-19 pill,” bringing the US’ total purchase to 3.1 m...
    Full Article
  • US Reopens Borders For Foreign Travelers Fully Vaccinated Against COVID-19

    The New York Times (11/8, Rivlin-Nadler) reports, “The United States reopened its borders for vaccinated foreign travelers on Monday, ending more than 18 months of restrictions on international travel that separated families and cost the global travel ind...
    Full Article
  • Regeneron Says COVID-19 Monoclonal Antibody Drug Reduces Risk Of Infection By 81.6%

    The Wall Street Journal (11/8, Walker, Subscription Publication) reports Regeneron Pharmaceuticals announced that its monoclonal antibody drug REGEN-COV for COVID-19 treatment continued to provide protection against the virus for eight months, and reduced...
    Full Article
  • Cell-Culture-Derived Quadrivalent Influenza Vaccine Appears Effective In Preventing Influenza Virus Infection In Children, Adolescents, Trial Indicates

    Infectious Disease Advisor (11/8, Mermelstein) reports, “An influenza vaccine derived from a mammalian Madin-Darby canine kidney (MDCK) cell line was effective in preventing influenza virus infection in children and adolescents, regardless of prior vaccin...
    Full Article
  • Long-Term Cognition Problems Following COVID-19 Infection Likely Due To Fatigue, Molecular Imaging Evidence Suggests

    HealthImaging (11/8, O'Connor) reports, “Long-term cognition problems following COVID-19 are likely due to fatigue rather than changes in the brain, according to new molecular imaging evidence” published in the Journal of Nuclear Medicine. According to th...
    Full Article
  • Over 250M COVID-19 Infections Reported Globally, Data Show

    CNN (11/8, McPhillips) reports, “More than 250 million cases of Covid-19 have been reported globally, according to data from Johns Hopkins University.” According to CNN, “The first 50 million cases were reported over the first eight months – a full year a...
    Full Article
  • Pfizer, BioNTech Slated To Seek Authorization For COVID-19 Vaccine Booster For All Adults

    The Washington Post (11/8, McGinley, Pager, Sun) reports Pfizer and partner BioNTech “are expected to seek authorization for their coronavirus vaccine booster shot for anyone 18 and older, a move that could increase booster rates at a critical moment in t...
    Full Article
  • EMA Reviewing Data For Merck’s COVID-19 Treatment

    The AP (11/8) reports the European Medicines Agency “on Monday began reviewing Merck’s COVID-19 treatment pill [molnupiravir] so that it can swiftly advise national drug authorities in the 27-nation bloc that want to begin using it before it gets official...
    Full Article
  • Rhinovirus Detected In Lungs Of Children With History Of Refractory Cough Associated With Bronchoalveolitis, Ciliary Dysfunction, Research Shows

    Pulmonology Advisor (11/8) reports, “Rhinovirus detected in the lungs of children with a history of refractory cough is associated with bronchoalveolitis and ciliary dysfunction, according to research.” The findings were presented at the 2021 ACAAI Annual...
    Full Article
  • Administration Urging Schools To Help Promote COVID-19 Vaccinations For Younger Children

    The New York Times (11/8, Stolberg) reports that First Lady Jill Biden and Surgeon General Vivek Murthy were in McLean, Virginia on Monday “to promote the vaccination of children in school against the coronavirus, visiting an elementary school whose stude...
    Full Article
  • Pfizer Says Its Antiviral Pill Demonstrates Efficacy Against COVID-19

    The New York Times (11/5, A1, Robbins) reported, “Pfizer announced on Friday that its pill to treat Covid-19 had been found in a key clinical trial to be highly effective at preventing severe illness among at-risk people who received the drug soon after t...
    Full Article
  • Repeat Viral RNA Testing Appears Ineffective In Determining Duration Of Viable Viral Shedding Among Patients With SARS-CoV-2 Infection, Systemic Review Suggests

    Infectious Disease Advisor (11/5, van Paridon) reported, “Results of a systemic review showed that repeat viral RNA testing is ineffective in determining the duration of viable viral shedding among patients with SARS-CoV-2 infection.” Investigators “searc...
    Full Article
  • Workers Cannot Self-Administer, Self-Report COVID-19 Tests Under Biden Administration Requirements

    The Wall Street Journal (11/5, Calfas, Cutter, Subscription Publication) reported that under the Biden Administration’s requirements mandating workers to either receive the COVID-19 vaccine or provide weekly test results, workers will not be allowed to se...
    Full Article
  • Novavax To Complete Submission Of COVID-19 Vaccine Data To FDA By Year End

    On its website, CNN (11/5, Howard) reported Novavax CEO Stanley Erck in a Friday interview revealed the company “plans to submit complete data to the US Food and Drug Administration soon for possible emergency use authorization of its coronavirus vaccine....
    Full Article
  • Researchers Explore Heart-Related Risks Tied To COVID-19 Vaccines

    The Wall Street Journal (11/7, Loftus, Subscription Publication) reports that as health authorities are expanding the use of COVID-19 vaccines in the US, researchers exploring heart-related risks tied to the shots, such as myocarditis or pericarditis, are...
    Full Article
  • «
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • »
Footer
Chicago (Headquarters)
33 West Monroe Street, Suite 1600, Chicago, IL 60603

Privacy Policy 

Terms of Use

Follow Us

Copyright ©2021  by American Society for Clinical Pathology. All Rights Reserved.

Chat With BOC

close
First Name *
Last Name *
Email *
Customer ID

Request a Call from Customer Relations

Close
Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id